Dynamics of high-sensitivity cardiac troponin T during therapy with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Steffen D KriechbaumChristoph B WiedenrothTill KellerJan Sebastian WolterRuth AjnwojnerKarina PetersMoritz A HaasFritz C RollerAndreas BreitheckerAndreas J RiethStefan GuthAndreas RolfDirk BandorskiChristian W HammEckhard MayerChristoph Liebetrau

Published in: PloS one (2018)

Non-invasive biomarker measurement provides valuable evidence for the decreasing impairment of myocardial function and structure during BPA therapy. Changes in hs-cTNT levels are suggestive for a reduction in ongoing myocardial damage.

Keyphrases

pulmonary hypertension
left ventricular
pulmonary artery
pulmonary arterial hypertension
oxidative stress
stem cells
atrial fibrillation
coronary artery
cell therapy